Baxter International | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Abbott USD 7.62B 58M 2024-12
AtriCure USD 122.72M 7.61M 2024-12
Avanos Medical USD 107.7M 18.7M 2024-12
Baxter International USD 1.76B 344M 2024-12
Becton, Dickinson and Co. USD 711M 1.01B 2024-12
Boston Scientific USD 414M 2.09B 2024-12
Cooper Companies USD 100.9M 6.7M 2025-01
Dexcom USD 606.1M 15.1M 2024-12
Edwards Lifesciences USD 3.05B 631.2M 2024-12
Fresenius EUR 2.28B 788M 2024-12
Globus Medical USD 784.44M 161.67M 2024-12
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
ICU Medical USD 308.57M 3.95M 2024-12
Insulet USD 820M 133.5M 2024-12
Integra LifeSciences USD 246.38M 31.22M 2024-12
Intuitive Surgical USD 8.83B 6.42B 2024-12
J&J USD 6.12B 1.28B 2024-12
Laboratory Of America USD 1.52B 1.4M 2024-12
Masimo USD 177.6M 19.1M 2024-12
Medtronic USD 1.24B 154M 2025-01
Merit Medical Systems USD 376.72M 146.41M 2024-12
Quest Diagnostics USD 549M 215M 2024-12
Smith & Nephew 568M 266M 2024-06
Stryker USD 3.65B 198M 2024-12
Tandem Diabetes Care USD 69.23M 20.2M 2024-12
Teleflex USD 290.19M 46.95M 2024-12
Terumo JPY 212.56B 17.64B 2024-12
Zimmer Biomet Holdings USD 525.5M 43.5M 2024-12



Baxter International Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.